The General Pharmaceutical Council (Registration Rules) Order of Council 2010

Renewal of an annotation made to an entry in the Register E+W+S

13.—(1) Subject to the following paragraphs, applicants for the renewal of an annotation in respect of a specialisation made to an entry in Part 1 or, as the case may be, Part 2 of the Register may apply to the Registrar.

(2) An application under this rule must be made to the Registrar no later than two months before the date on which the entry in the Register to which the annotation relates would cease to be valid if not renewed using the relevant application form which must be in such form as the Council may from time to time determine.

(3) The Registrar must send to each registrant whose entry in Part 1 or, as the case may be, Part 2 of the Register is annotated to denote a specialisation an application form at least three months before the date on which the registrant’s entry in the relevant part of the Register would cease to be valid if not renewed.

(4) The application form must, in particular—

(a) include a demand that the registrant pay the prescribed fee in respect of the application; and

(b) require the applicant to—

(i) provide the applicant’s full name, home address and contact details (including a telephone number and electronic mail address, where possible),

(ii) specify whether the application relates to an entry in Part 1 or Part 2 of the Register,

(iii) specify the number of the entry in the Register to which the application relates,

[F1 (iiia) specify whether, if an annotation in respect of a specialisation were to be renewed, there would be in force an indemnity arrangement which provides appropriate cover in relation to the applicant,]

(iv) provide any other necessary supporting documents, information or evidence as mentioned in the application, and

(v) sign and date the application.

(5) The applicant must also provide such additional documents, information or evidence as the Registrar may reasonably require for the purposes of verifying the information in, or determining, the application.

(6) The Registrar must refuse any application under this rule—

(a) if it is not received by the Registrar within the time limit specified in paragraph (2);

(b) if it is not accompanied by the necessary supporting documents, information or evidence as mentioned in the application form [F2 or subsequently required by the Registrar]; or

(c) if the applicant has not paid, or has not made arrangements with the Registrar to pay by direct debit, the prescribed fee in respect of the application.

(7) If a registrant with an annotation in respect of a specialisation made to an entry in Part 1 or, as the case may be, Part 2 of the Register has not received an application form for the renewal of that annotation by the beginning of the period of three months before the date on which the registrant’s entry in the Register would cease to be valid if not renewed, the registrant must notify the Registrar accordingly.

Textual Amendments

F1 Sch. rule 13(4)(b)(iiia) inserted (21.11.2016) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2016 (S.I. 2016/1008), art. 1, Sch. rule 7(2)

F2 Words in Sch. rule 13(6)(b) inserted (21.11.2016) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2016 (S.I. 2016/1008), art. 1, Sch. rule 7(3)

Commencement Information

I1 Sch. rule 13 in force at 4.1.2011, see art. 1(2)